MPLT

MapLight Therapeutics, Inc. · Healthcare · Market cap $374.4M

Insiders sold $12.6M net in the last 90 days ·6 sellers, 1 buyer· 11 of 26 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 16, 2026

Insider Buying

$17.0M

reported purchases (SEC code P)

Insider Selling

$30.2M

reported sales (SEC code S)

Unique Insiders

12

in the rolling window

Latest filing

Oct 16, 2026

Kroeger Christopher A.

MapLight Therapeutics, Inc. (MPLT) has 79 SEC Form 4 filings (191 transaction rows) in the rolling window, disclosed by 12 distinct insiders. Most recent filing: Oct 16, 2026.

Inside the rolling window, 12 insiders at MapLight Therapeutics, Inc. reported 6 open-market purchases totaling $17.0M and 73 open-market sales totaling $30.2M. The most active filer is Chief Executive Officer Kroeger Christopher A. with 13 filings. Insiders have net sold $27.4M over the trailing 6 months. The most recent open-market filing is a sale of 73,691 shares by Chief Executive Officer Kroeger Christopher A., dated Oct 15, 2026, worth $595K.

  • Industry:Biotechnology
  • CEO:Christopher A. Kroeger
  • Employees:133
  • HQ:Redwood City, CA, US
  • IPO:2025-10-24
Source
Sale$595KOct 16SEC ↗
Sale$93KOct 16SEC ↗
Sale$73KOct 16SEC ↗
Sale$96KOct 16SEC ↗
Sale$82KOct 16SEC ↗
Sale$124KOct 16SEC ↗
Sale$193KSep 18SEC ↗
Sale$277KAug 5SEC ↗
Cox TroyFirst filing
Purchase$149KJul 29SEC ↗
Sale$367KJul 20SEC ↗
Sale$311KJul 20SEC ↗
Sale$694KJul 20SEC ↗
Sale$367KJul 20SEC ↗
Sale$333KJul 20SEC ↗
Sale$646KJul 20SEC ↗
Sale$2.3MJul 18SEC ↗
Sale$2.5MJul 18SEC ↗
Sale$636KJul 18SEC ↗
Sale$281KJul 18SEC ↗
Sale$314KJul 18SEC ↗
Sale$79KJul 18SEC ↗
Sale$266KJul 18SEC ↗
Sale$299KJul 18SEC ↗
Sale$43KJul 18SEC ↗
Sale$1.0MJul 18SEC ↗
Showing 1–25 of 79
1 / 4

Earnings: last 7 quarters

EstimatedActual

Frequently asked questions

How many SEC Form 4 insider filings does MPLT have?

MapLight Therapeutics, Inc. (MPLT) has 79 SEC Form 4 filings (191 transaction rows) in the rolling 365-day window, disclosed by 12 distinct insiders. Most recent filing: Oct 16, 2026.

When was the most recent SEC Form 4 filing for MPLT?

The most recent Form 4 filing for MPLT on Tracefour is dated Oct 16, 2026.

Who is the most active insider at MPLT?

The most active SEC Form 4 filer at MPLT in the rolling window is Chief Executive Officer Kroeger Christopher A., with 13 filings.

What is the net insider flow at MPLT over the last 6 months?

Over the trailing 180 days, insiders at MPLT have net sold $27.4M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at MPLT in the current window?

Inside the rolling window, insiders at MPLT bought $17.0M and sold $30.2M based on SEC Form 4 filings.

Can I get alerts for MPLT insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at MapLight Therapeutics, Inc. (MPLT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

MapLight Therapeutics, Inc. is in the Healthcare sector.